3. CEO’S MESSAGE
Aspirations 7
INTRODUCTION
Birth 9
ROAD MAP
Code 11
Path 11
Secret 13
BUSINESS FOCUS
Investments 15
Newbridge pharmceuticals 17
Contents
Clinart 19
Orzone 21
Medical Technologies 23
Life Science Academy 25
CONTACT 27
4. CEO’S MESSAGE
ASPIRATIONS
“ The Gulf region and greater Middle East
is currently ripe for opportunities and
potential growth, but with challenges.
KLSC is uniquely positioned to help
various regional and international
companies capture lucrative
opportunities, accommodate the
inherent challenges and reap the great
“
rewards that come with them
Qais Marafie
Chief Executive Officer
7
5. Introduction
Birth
• Kuwait Life Sciences Company is fully owned by Kuwait Investment
Authority (KIA) and its subsidiary National Technology Enterprises Company
(NTEC). KLSC is capitalized at 9 million Kuwaiti Dinars. KLSC supports both
public and private sectors to access emerging technologies and adopt best
practices prevailing in today’s healthcare systems
• Kuwait Life Sciences Company is fully owned by National Technology
Enterprises Company (NTEC). KLSC supports both public and private sectors
to access emerging technologies and adopt best practices prevailing in
today’s healthcare systems
• NTEC which was established in 2004 by ‘Kuwait Council of Ministers’, fully
owned by the Kuwait Investment Authority (KIA) and mandated to transfer
technology and know-how to Kuwait by creating and investing in projects
with advanced technologies
9
6. Road Map
Code
• To engage in a unique role of developing and advancing the local & regional
healthcare systems and services
• To accelerate the transfer of best in-class technologies and innovative
business models practiced globally to match the needs and demands of
Kuwait & the Gulf region
• To present healthcare professionals with distinguished opportunities for
development and growth in synchronization with international standards
and modern practices
Path
• KLSC integrates unique solutions for unmet medical need
• KLSC transmigrate international business opportunities and technologies
to contribute to the development of the region and enhance the skills and
capabilities of healthcare professionals and leaders
• KLSC lives among distinguished partners, capable allies, and renowned
experts to breed significant value to the life sciences industry
11
7. Road Map
Secret
• Innovation: We continue to build an internal environment of innovation
to couple unique initiatives, technologies or intellects.
• Synergy: We connect the dots and strive to Synergize ideas, concepts,
teams and projects
• Passion: We seek to hire and work with those who have passion for
excellence, differentiation, and superior performance
• Vitality: We live our day dream as a team and execute our responsibilities
with Vitality
• Integrity: We inhabit ethics in our relationships with healthcare
professionals, patients and community and processes science and education
with Integrity
13
8. Business Focus
Investments
• KLSC has a broad international network of venture capital and private
equity funds, technology transfer centers, multinational pharmaceutical
companies, and scientific experts across various life science fields. KLSC
leverages on the exposure and expertise of its parent company NTEC and
also the vast network & strengths of KIA to actively invest in innovative
companies and bright teams
• KLSC looks for opportunities from start-up projects requiring seed capital
to established businesses looking for growth capital. KLSC is a medium
to long term investor leading or co-leading regional projects in the MENA
region
• KLSC major areas of investment are in medical technology, diagnostics,
pharmaceuticals and healthcare services which address critical and prevalent
diseases
• KLSC also works actively with the its portfolio management team to
accelerate product penetration into the Gulf and Middle East, finding and
expanding the right team and the overall execution of the strategy
• KLSC has successful investments in several international companies at
early and late stage. Among which are Immatics Biotechnologies GmbH
(Germany), Oxford Immunotec (UK), StemCyte Inc. (USA), MTM Laboratories
AG. (Germany & USA), Median Technologies (France), Orzone (Sweden)
• KLSC invested in reputed life sciences funds like Wellington Partners
(Germany), Burrill & Co. (USA) , CMEA (USA). Regional Investments include:
NewBridge Pharmaceuticals and Clinart MENA
15
9. Strategic Investments
NEWBRIDGE PHARMACEUTICALS
NewBridge Pharmaceuticals (NBP), headquartered in Dubai, is a first-inclass
specialty therapeutics company focused on innovative pharmaceuticals and
biotechnological medicines.
NBP specializes in licensing, registering and commercializing FDA, EMA/
European and Japanese (PMDA) approved therapeutics, to address the unmet
medical needs of diseases with high regional prevalence in the Middle East,
Africa, Turkey and Caspian (AFMET) regions.
NewBridge focuses on products for oncology and supportive care, metabolic
disorders, gastrointestinal conditions and other specialty segments.
Planned future expansion includes establishing NBP own branded products
through the establishment of manufacturing and R&D capabilities.
www.nbpharma.com
17
10. Strategic Investments
CLINART MENA
ClinArt is a full service Contract Research Organization (CRO), headquartered
in Dubai Health Care City, which brings an international clinical research
expertise and quality services to the Middle East region in line with local
cultures and customs.
Clinart MNEA has a proven track record of successful clinical trials covering
phase II, III and phase IV; also known as post-marketing studies. The company
has strong relationships with various multinational pharmaceutical companies
which become permanent clients perceiving that Clinart is the right vendor for
the MENA region.
Clinical research awareness is among the prime objectives of Clinart & to
foster clinical research culture and infrastructure in the MENA region. ClinArt
has offices in Egypt, Saudi Arabia, and Lebanon, through which it operates in
the broader Middle East.
www.clinart.net
19
11. Strategic Investments
Orzone
Orzone is a medical training company that focus on improving medical outcome
by developing creative tools, which support training and assessments of
medical skills.
Orzone products are based on e-learning and advanced simulation technology
for individuals or teams. Orzone is committed to improve healthcare quality
and minimize the risk of medical errors by facilitating medical training.
Orzone was founded by leading industry experts. The Orzone team is an
innovative force globally and has experience from over 500 training installations
and its use in 200 published scientific peer-reviewed studies.
Orzone is based in Gothenburg, Sweden. In February 2013 the first GCC regional
office was establish in Dubai.
www.orzone.com
21
12. Business Focus
Medical Technologies
• KLSC commercializes innovative medical technologies companies which
enhance the quality and speed of diagnostics, through the retail of high
tech. medical instruments, consumables and reagents
• KLSC provides vital services aiming to combat majority of critical clinical
areas in this emerging region. Our broad range of innovative diagnostic
tests and systems play a vital role in the area of integrated healthcare
solutions and cover the early detection, targeted screening, evaluation and
monitoring of disease
• KLSC fully supports its partners and suppliers who are located worldwide
spanning over the US, Canada, central Europe and South Asia, by a
proffesional team of sales, marketing and technical support; to further
penetrate Middle Eastern countries and contribute to the advancement of
healthcare services
• Medical technologies department specializes in; laboratory diagnostics,
surgical & Imaging, mobile Health and screening programmes (Diabetes &
Cancer)
23
13. Business Focus
Life Science Academy
• KLSC established the first healthcare academy in the GCC region that
provides revolutionary knowledge, education and professional development
programs across all healthcare sectors
• Life Science Academy offers a unique platform for Continuous Professional
Development (CPD) programs and lucrative opportunity to be abreast of
international practices. The Life Science Academy aims to facilitate the
transfer of latest technologies & practices in healthcare services and
bridges the strategic gap in know-how and best practices sought by local
& regional healthcare community
• Life Science Academy functions in collaboration and affiliation of international
medical universities, reputed academies & recognized institutes whether
for profit or non-profit organizations
• Life Science Academy courses are targeted towards nurses, pharmacists,
physicians, surgeons, biomedical engineers as well as leaders & managers
across sectors of healthcare industry
25
14. Contact
Address
Kuwait Life Sciences Company
KIPCO Tower 27th floor,
Al Shohadaa Street,
Block 9, Kuwait City, Kuwait
P.O. Box 25363, Safat 13114, Kuwait
Telephone
+965 22490969 – 22479787
Fax
+965 22490959
Website
www.klsc.com.kw
27
15. Innovative Investments Advancing Healthcare
�شركة مملوكة بالكامل للوطنية مل�شاريع التكنولوجيا �ش م ك م
Fully owned by the National Technology Enterprises Company KCSC
